

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 4.83324208 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.83324208 |
| 3 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.62842990 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.46703178 |
| 5 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.13305076 |
| 6 | tachykinin receptor signaling pathway (GO:0007217) | 4.11868754 |
| 7 | immunoglobulin mediated immune response (GO:0016064) | 3.85698156 |
| 8 | B cell receptor signaling pathway (GO:0050853) | 3.60387625 |
| 9 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.58165184 |
| 10 | positive regulation of B cell differentiation (GO:0045579) | 3.50124725 |
| 11 | negative thymic T cell selection (GO:0045060) | 3.46856424 |
| 12 | regulation of B cell differentiation (GO:0045577) | 3.44994654 |
| 13 | activated T cell proliferation (GO:0050798) | 3.41661993 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.34987948 |
| 15 | positive regulation of granulocyte differentiation (GO:0030854) | 3.34900933 |
| 16 | negative T cell selection (GO:0043383) | 3.30896363 |
| 17 | positive T cell selection (GO:0043368) | 3.28957145 |
| 18 | negative regulation of mast cell activation (GO:0033004) | 3.24260644 |
| 19 | T cell migration (GO:0072678) | 3.22241078 |
| 20 | positive thymic T cell selection (GO:0045059) | 3.20760127 |
| 21 | cellular response to interleukin-15 (GO:0071350) | 3.15929291 |
| 22 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.15217041 |
| 23 | neural tube formation (GO:0001841) | 3.13349779 |
| 24 | positive regulation of action potential (GO:0045760) | 3.02101737 |
| 25 | regulation of mast cell activation (GO:0033003) | 3.00603032 |
| 26 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.99199263 |
| 27 | aggressive behavior (GO:0002118) | 2.97690694 |
| 28 | interferon-gamma production (GO:0032609) | 2.95921643 |
| 29 | regulation of gamma-delta T cell activation (GO:0046643) | 2.95107384 |
| 30 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.93924650 |
| 31 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.93746675 |
| 32 | regulation of germinal center formation (GO:0002634) | 2.92879093 |
| 33 | B cell mediated immunity (GO:0019724) | 2.87535770 |
| 34 | adaptation of signaling pathway (GO:0023058) | 2.86193364 |
| 35 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.84931754 |
| 36 | tolerance induction (GO:0002507) | 2.82900381 |
| 37 | response to interleukin-15 (GO:0070672) | 2.82633438 |
| 38 | response to peptidoglycan (GO:0032494) | 2.81446351 |
| 39 | regulation of cilium movement (GO:0003352) | 2.78847757 |
| 40 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.74565022 |
| 41 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.74186413 |
| 42 | inositol phosphate catabolic process (GO:0071545) | 2.72410649 |
| 43 | neutrophil mediated immunity (GO:0002446) | 2.70329259 |
| 44 | T cell selection (GO:0045058) | 2.70168596 |
| 45 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.66930564 |
| 46 | regulation of action potential (GO:0098900) | 2.66595862 |
| 47 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.65888323 |
| 48 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.65888323 |
| 49 | modulation by symbiont of host immune response (GO:0052553) | 2.65888323 |
| 50 | positive regulation by symbiont of host defense response (GO:0052509) | 2.65888323 |
| 51 | modulation by symbiont of host defense response (GO:0052031) | 2.65888323 |
| 52 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.65888323 |
| 53 | response to muramyl dipeptide (GO:0032495) | 2.63077192 |
| 54 | regulation of antigen processing and presentation (GO:0002577) | 2.62074297 |
| 55 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.61736904 |
| 56 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.58883973 |
| 57 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.58076071 |
| 58 | defense response to protozoan (GO:0042832) | 2.58064956 |
| 59 | pyrimidine dimer repair (GO:0006290) | 2.56621653 |
| 60 | presynaptic membrane assembly (GO:0097105) | 2.56178455 |
| 61 | histone H3-K9 modification (GO:0061647) | 2.55901818 |
| 62 | histone H3-K9 methylation (GO:0051567) | 2.54290398 |
| 63 | regulation of mast cell degranulation (GO:0043304) | 2.54199808 |
| 64 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.51717276 |
| 65 | positive regulation of mast cell activation (GO:0033005) | 2.49398119 |
| 66 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.49015273 |
| 67 | RNA destabilization (GO:0050779) | 2.46354981 |
| 68 | cellular extravasation (GO:0045123) | 2.45660337 |
| 69 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.45464585 |
| 70 | neutrophil activation involved in immune response (GO:0002283) | 2.45317425 |
| 71 | germinal center formation (GO:0002467) | 2.45106412 |
| 72 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.43359879 |
| 73 | positive regulation of interleukin-2 production (GO:0032743) | 2.41572599 |
| 74 | DNA double-strand break processing (GO:0000729) | 2.38825504 |
| 75 | positive regulation of T cell cytokine production (GO:0002726) | 2.38597964 |
| 76 | microglial cell activation (GO:0001774) | 2.38131215 |
| 77 | neutrophil activation (GO:0042119) | 2.37247537 |
| 78 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.36897757 |
| 79 | negative regulation of protein oligomerization (GO:0032460) | 2.36571885 |
| 80 | negative regulation of T cell mediated immunity (GO:0002710) | 2.35662425 |
| 81 | myeloid leukocyte mediated immunity (GO:0002444) | 2.35404512 |
| 82 | regulation of heat generation (GO:0031650) | 2.35174836 |
| 83 | response to auditory stimulus (GO:0010996) | 2.33215432 |
| 84 | macrophage activation involved in immune response (GO:0002281) | 2.33152104 |
| 85 | response to protozoan (GO:0001562) | 2.32802235 |
| 86 | detection of bacterium (GO:0016045) | 2.32782612 |
| 87 | detection of other organism (GO:0098543) | 2.32370876 |
| 88 | neuron cell-cell adhesion (GO:0007158) | 2.32341086 |
| 89 | regulation of feeding behavior (GO:0060259) | 2.32295359 |
| 90 | retinal cone cell development (GO:0046549) | 2.30245342 |
| 91 | glycosphingolipid biosynthetic process (GO:0006688) | 2.29828935 |
| 92 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.29682744 |
| 93 | positive regulation of interleukin-17 production (GO:0032740) | 2.27815665 |
| 94 | nucleobase catabolic process (GO:0046113) | 2.27277187 |
| 95 | response to host immune response (GO:0052572) | 2.26814245 |
| 96 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.26814245 |
| 97 | negative regulation of type 2 immune response (GO:0002829) | 2.25956644 |
| 98 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.25464383 |
| 99 | regulation of mitochondrial depolarization (GO:0051900) | 2.25451802 |
| 100 | adenosine metabolic process (GO:0046085) | 2.25253051 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.96882973 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.57909295 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.28584722 |
| 4 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.11526960 |
| 5 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.00328182 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.91737245 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.44497830 |
| 8 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.41672634 |
| 9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.27154560 |
| 10 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.25240329 |
| 11 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.19003233 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.18164163 |
| 13 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.11378396 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.08135327 |
| 15 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.03774676 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.98343978 |
| 17 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.95532300 |
| 18 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.94893084 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.91097294 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.81393130 |
| 21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78328390 |
| 22 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.75348166 |
| 23 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.72682167 |
| 24 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.72490118 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 1.68646821 |
| 26 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.57669884 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.53647908 |
| 28 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.51417808 |
| 29 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.47434707 |
| 30 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.47434707 |
| 31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.43823359 |
| 32 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.42548624 |
| 33 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.41108312 |
| 34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38526745 |
| 35 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.38069557 |
| 36 | GATA3_26560356_Chip-Seq_TH2_Human | 1.37045361 |
| 37 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.35048866 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33582510 |
| 39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.32864520 |
| 40 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.32043736 |
| 41 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.31627961 |
| 42 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.31584058 |
| 43 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.31553558 |
| 44 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.30925473 |
| 45 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.28152776 |
| 46 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.26337095 |
| 47 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.26243367 |
| 48 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.25959650 |
| 49 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.25767235 |
| 50 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.25636495 |
| 51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.24773047 |
| 52 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.24699316 |
| 53 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.23951432 |
| 54 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18284494 |
| 55 | VDR_22108803_ChIP-Seq_LS180_Human | 1.18188879 |
| 56 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.17883641 |
| 57 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17543968 |
| 58 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.16970363 |
| 59 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.16273516 |
| 60 | MYB_26560356_Chip-Seq_TH1_Human | 1.11662180 |
| 61 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.11650735 |
| 62 | P300_19829295_ChIP-Seq_ESCs_Human | 1.11030067 |
| 63 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.08897458 |
| 64 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.08391678 |
| 65 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.05557440 |
| 66 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05137076 |
| 67 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.02598435 |
| 68 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01784479 |
| 69 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.01281187 |
| 70 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00349426 |
| 71 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.99807760 |
| 72 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99407339 |
| 73 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.98714668 |
| 74 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.97529641 |
| 75 | STAT3_23295773_ChIP-Seq_U87_Human | 0.97510606 |
| 76 | TCF4_23295773_ChIP-Seq_U87_Human | 0.97494422 |
| 77 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.97432760 |
| 78 | AR_25329375_ChIP-Seq_VCAP_Human | 0.97162165 |
| 79 | UTX_26944678_Chip-Seq_JUKART_Human | 0.97037754 |
| 80 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.96938294 |
| 81 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.96669465 |
| 82 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.96589581 |
| 83 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.96267075 |
| 84 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.95035252 |
| 85 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.94346825 |
| 86 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94143659 |
| 87 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.94143659 |
| 88 | FUS_26573619_Chip-Seq_HEK293_Human | 0.93941510 |
| 89 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.93811739 |
| 90 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92766339 |
| 91 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.92025486 |
| 92 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.90991598 |
| 93 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.90761413 |
| 94 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.90615946 |
| 95 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.90023609 |
| 96 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.89206131 |
| 97 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.89162312 |
| 98 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87758516 |
| 99 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.84206328 |
| 100 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.83548805 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.90357368 |
| 2 | MP0003724_increased_susceptibility_to | 3.26189503 |
| 3 | MP0001968_abnormal_touch/_nociception | 2.89854821 |
| 4 | MP0008877_abnormal_DNA_methylation | 2.87435363 |
| 5 | MP0003787_abnormal_imprinting | 2.69388349 |
| 6 | MP0003436_decreased_susceptibility_to | 2.68636628 |
| 7 | MP0002735_abnormal_chemical_nociception | 2.46882207 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.44829814 |
| 9 | MP0001986_abnormal_taste_sensitivity | 2.28034693 |
| 10 | MP0001800_abnormal_humoral_immune | 2.26331466 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 2.15396443 |
| 12 | MP0002102_abnormal_ear_morphology | 2.06426324 |
| 13 | MP0005671_abnormal_response_to | 2.05159672 |
| 14 | MP0002736_abnormal_nociception_after | 2.02326133 |
| 15 | MP0005084_abnormal_gallbladder_morpholo | 1.98200638 |
| 16 | MP0001529_abnormal_vocalization | 1.98158572 |
| 17 | MP0005000_abnormal_immune_tolerance | 1.93384268 |
| 18 | MP0000465_gastrointestinal_hemorrhage | 1.81961737 |
| 19 | MP0003880_abnormal_central_pattern | 1.78367488 |
| 20 | MP0002723_abnormal_immune_serum | 1.73608648 |
| 21 | MP0002420_abnormal_adaptive_immunity | 1.67408654 |
| 22 | MP0001819_abnormal_immune_cell | 1.63725783 |
| 23 | MP0004142_abnormal_muscle_tone | 1.61524744 |
| 24 | MP0002277_abnormal_respiratory_mucosa | 1.60245363 |
| 25 | MP0001984_abnormal_olfaction | 1.59858889 |
| 26 | MP0002452_abnormal_antigen_presenting | 1.58952144 |
| 27 | MP0002419_abnormal_innate_immunity | 1.58221760 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 1.55468441 |
| 29 | MP0003763_abnormal_thymus_physiology | 1.53256811 |
| 30 | MP0001790_abnormal_immune_system | 1.53233198 |
| 31 | MP0005387_immune_system_phenotype | 1.53233198 |
| 32 | MP0005025_abnormal_response_to | 1.46775997 |
| 33 | MP0000604_amyloidosis | 1.38671245 |
| 34 | MP0000685_abnormal_immune_system | 1.37920909 |
| 35 | MP0003635_abnormal_synaptic_transmissio | 1.36314775 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.35366613 |
| 37 | MP0002398_abnormal_bone_marrow | 1.34938462 |
| 38 | MP0003329_amyloid_beta_deposits | 1.34623599 |
| 39 | MP0009764_decreased_sensitivity_to | 1.32789410 |
| 40 | MP0005075_abnormal_melanosome_morpholog | 1.32721735 |
| 41 | MP0000716_abnormal_immune_system | 1.27428837 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.26041275 |
| 43 | MP0003172_abnormal_lysosome_physiology | 1.20612487 |
| 44 | MP0002722_abnormal_immune_system | 1.18321052 |
| 45 | MP0002148_abnormal_hypersensitivity_rea | 1.16761316 |
| 46 | MP0009785_altered_susceptibility_to | 1.14995492 |
| 47 | MP0009745_abnormal_behavioral_response | 1.14035068 |
| 48 | MP0001545_abnormal_hematopoietic_system | 1.13419821 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.13419821 |
| 50 | MP0002405_respiratory_system_inflammati | 1.12531961 |
| 51 | MP0003183_abnormal_peptide_metabolism | 1.12516406 |
| 52 | MP0002653_abnormal_ependyma_morphology | 1.12181636 |
| 53 | MP0004924_abnormal_behavior | 1.10959117 |
| 54 | MP0005386_behavior/neurological_phenoty | 1.10959117 |
| 55 | MP0006082_CNS_inflammation | 1.07300611 |
| 56 | MP0005310_abnormal_salivary_gland | 1.06842291 |
| 57 | MP0000703_abnormal_thymus_morphology | 1.05909058 |
| 58 | MP0004859_abnormal_synaptic_plasticity | 1.04227304 |
| 59 | MP0003646_muscle_fatigue | 1.03484531 |
| 60 | MP0001533_abnormal_skeleton_physiology | 1.03356807 |
| 61 | MP0005423_abnormal_somatic_nervous | 1.02396672 |
| 62 | MP0004145_abnormal_muscle_electrophysio | 1.01410136 |
| 63 | MP0002733_abnormal_thermal_nociception | 1.01172373 |
| 64 | MP0002572_abnormal_emotion/affect_behav | 0.98827493 |
| 65 | MP0002822_catalepsy | 0.98432168 |
| 66 | MP0004885_abnormal_endolymph | 0.98363719 |
| 67 | MP0002063_abnormal_learning/memory/cond | 0.97479554 |
| 68 | MP0008995_early_reproductive_senescence | 0.97165163 |
| 69 | MP0002254_reproductive_system_inflammat | 0.94164049 |
| 70 | MP0002067_abnormal_sensory_capabilities | 0.93510127 |
| 71 | MP0002734_abnormal_mechanical_nocicepti | 0.93410664 |
| 72 | MP0000516_abnormal_urinary_system | 0.93400096 |
| 73 | MP0005367_renal/urinary_system_phenotyp | 0.93400096 |
| 74 | MP0001845_abnormal_inflammatory_respons | 0.92871871 |
| 75 | MP0001970_abnormal_pain_threshold | 0.91851780 |
| 76 | MP0004883_abnormal_blood_vessel | 0.90783219 |
| 77 | MP0002429_abnormal_blood_cell | 0.90451469 |
| 78 | MP0002064_seizures | 0.89937822 |
| 79 | MP0002837_dystrophic_cardiac_calcinosis | 0.86460053 |
| 80 | MP0005253_abnormal_eye_physiology | 0.85068864 |
| 81 | MP0009278_abnormal_bone_marrow | 0.84186185 |
| 82 | MP0004130_abnormal_muscle_cell | 0.84150716 |
| 83 | MP0001486_abnormal_startle_reflex | 0.83622575 |
| 84 | MP0006054_spinal_hemorrhage | 0.83442434 |
| 85 | MP0005535_abnormal_body_temperature | 0.82795260 |
| 86 | MP0003806_abnormal_nucleotide_metabolis | 0.81777861 |
| 87 | MP0002928_abnormal_bile_duct | 0.80727710 |
| 88 | MP0005220_abnormal_exocrine_pancreas | 0.80315987 |
| 89 | MP0004484_altered_response_of | 0.80070069 |
| 90 | MP0005551_abnormal_eye_electrophysiolog | 0.78792457 |
| 91 | MP0004270_analgesia | 0.77839402 |
| 92 | MP0005394_taste/olfaction_phenotype | 0.77640962 |
| 93 | MP0005499_abnormal_olfactory_system | 0.77640962 |
| 94 | MP0009046_muscle_twitch | 0.75936833 |
| 95 | MP0003828_pulmonary_edema | 0.75185174 |
| 96 | MP0005645_abnormal_hypothalamus_physiol | 0.74204749 |
| 97 | MP0004811_abnormal_neuron_physiology | 0.74082083 |
| 98 | MP0002638_abnormal_pupillary_reflex | 0.72875436 |
| 99 | MP0002332_abnormal_exercise_endurance | 0.72791466 |
| 100 | MP0002396_abnormal_hematopoietic_system | 0.72706663 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 4.86679196 |
| 2 | Amyotrophic lateral sclerosis (HP:0007354) | 4.43278483 |
| 3 | Methylmalonic acidemia (HP:0002912) | 4.03321860 |
| 4 | Papilledema (HP:0001085) | 4.02794499 |
| 5 | Methylmalonic aciduria (HP:0012120) | 3.98466814 |
| 6 | Stomach cancer (HP:0012126) | 3.69101295 |
| 7 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.51942461 |
| 8 | Recurrent cutaneous fungal infections (HP:0011370) | 3.51942461 |
| 9 | Polyphagia (HP:0002591) | 3.38716799 |
| 10 | Panhypogammaglobulinemia (HP:0003139) | 3.25873141 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 3.15529648 |
| 12 | Recurrent abscess formation (HP:0002722) | 3.15355348 |
| 13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.12651095 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 3.12274403 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.11454368 |
| 16 | Meningitis (HP:0001287) | 2.87179630 |
| 17 | Agammaglobulinemia (HP:0004432) | 2.84983038 |
| 18 | Hyperventilation (HP:0002883) | 2.74789929 |
| 19 | Absent speech (HP:0001344) | 2.73838582 |
| 20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.69120171 |
| 21 | Encephalitis (HP:0002383) | 2.63253805 |
| 22 | Severe combined immunodeficiency (HP:0004430) | 2.61650224 |
| 23 | Gait imbalance (HP:0002141) | 2.47421671 |
| 24 | Recurrent skin infections (HP:0001581) | 2.47356110 |
| 25 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.44124813 |
| 26 | Medial flaring of the eyebrow (HP:0010747) | 2.42921054 |
| 27 | IgG deficiency (HP:0004315) | 2.36029250 |
| 28 | Leukocytosis (HP:0001974) | 2.35538975 |
| 29 | Eczematoid dermatitis (HP:0000976) | 2.34297552 |
| 30 | Nephrogenic diabetes insipidus (HP:0009806) | 2.33077795 |
| 31 | Thyroiditis (HP:0100646) | 2.29490716 |
| 32 | Optic neuritis (HP:0100653) | 2.29123807 |
| 33 | Retrobulbar optic neuritis (HP:0100654) | 2.29123807 |
| 34 | Chest pain (HP:0100749) | 2.28876406 |
| 35 | Abnormality of eosinophils (HP:0001879) | 2.26930475 |
| 36 | Abnormality of macrophages (HP:0004311) | 2.26921014 |
| 37 | Abnormality of T cells (HP:0002843) | 2.26159308 |
| 38 | Abnormality of vitamin B metabolism (HP:0004340) | 2.24992272 |
| 39 | T lymphocytopenia (HP:0005403) | 2.24691001 |
| 40 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.21512365 |
| 41 | Myositis (HP:0100614) | 2.19991256 |
| 42 | Hemiplegia (HP:0002301) | 2.19588917 |
| 43 | Agnosia (HP:0010524) | 2.17138677 |
| 44 | Congenital primary aphakia (HP:0007707) | 2.15078805 |
| 45 | Abnormality of the prostate (HP:0008775) | 2.13355175 |
| 46 | Hemiparesis (HP:0001269) | 2.12496602 |
| 47 | Abnormality of T cell number (HP:0011839) | 2.10848781 |
| 48 | Pulmonary infiltrates (HP:0002113) | 2.08288383 |
| 49 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.07040796 |
| 50 | Dicarboxylic aciduria (HP:0003215) | 2.07040796 |
| 51 | Hematochezia (HP:0002573) | 2.06821977 |
| 52 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.06596946 |
| 53 | Agitation (HP:0000713) | 2.06418142 |
| 54 | Recurrent sinusitis (HP:0011108) | 2.05039713 |
| 55 | Eosinophilia (HP:0001880) | 2.03603510 |
| 56 | Urticaria (HP:0001025) | 2.03153983 |
| 57 | Abnormality of T cell physiology (HP:0011840) | 2.01963339 |
| 58 | Increased IgM level (HP:0003496) | 2.00217233 |
| 59 | Orchitis (HP:0100796) | 1.98578442 |
| 60 | Abnormal eating behavior (HP:0100738) | 1.96478366 |
| 61 | Keratoconjunctivitis (HP:0001096) | 1.95469624 |
| 62 | Vasculitis (HP:0002633) | 1.93607844 |
| 63 | Hip dysplasia (HP:0001385) | 1.92518652 |
| 64 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.91956444 |
| 65 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.91956444 |
| 66 | Tented upper lip vermilion (HP:0010804) | 1.90173883 |
| 67 | Hypochromic microcytic anemia (HP:0004840) | 1.89826220 |
| 68 | Hemoptysis (HP:0002105) | 1.89364880 |
| 69 | Combined immunodeficiency (HP:0005387) | 1.87752931 |
| 70 | Asplenia (HP:0001746) | 1.87720492 |
| 71 | Abolished electroretinogram (ERG) (HP:0000550) | 1.84743284 |
| 72 | Granulocytopenia (HP:0001913) | 1.81470422 |
| 73 | IgM deficiency (HP:0002850) | 1.80965771 |
| 74 | Thyroid-stimulating hormone excess (HP:0002925) | 1.80661898 |
| 75 | Recurrent viral infections (HP:0004429) | 1.80559459 |
| 76 | Dialeptic seizures (HP:0011146) | 1.80333835 |
| 77 | Abnormality of B cell number (HP:0010975) | 1.80240041 |
| 78 | Hyperglycinemia (HP:0002154) | 1.80142079 |
| 79 | Lissencephaly (HP:0001339) | 1.80025092 |
| 80 | Disinhibition (HP:0000734) | 1.79658346 |
| 81 | Attenuation of retinal blood vessels (HP:0007843) | 1.79615177 |
| 82 | Ankle clonus (HP:0011448) | 1.79039938 |
| 83 | Papilloma (HP:0012740) | 1.78838414 |
| 84 | Verrucae (HP:0200043) | 1.78838414 |
| 85 | Chronic diarrhea (HP:0002028) | 1.77905835 |
| 86 | Oligomenorrhea (HP:0000876) | 1.77712109 |
| 87 | Intestinal atresia (HP:0011100) | 1.77665936 |
| 88 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.77569709 |
| 89 | Alveolar cell carcinoma (HP:0006519) | 1.77088878 |
| 90 | Broad-based gait (HP:0002136) | 1.76657423 |
| 91 | Spastic gait (HP:0002064) | 1.73581851 |
| 92 | Keratoconjunctivitis sicca (HP:0001097) | 1.72615017 |
| 93 | Acute hepatic failure (HP:0006554) | 1.69910058 |
| 94 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.69624468 |
| 95 | Ketosis (HP:0001946) | 1.69468175 |
| 96 | Atonic seizures (HP:0010819) | 1.69164904 |
| 97 | Lymphopenia (HP:0001888) | 1.68612560 |
| 98 | Chronic obstructive pulmonary disease (HP:0006510) | 1.68129527 |
| 99 | Obstructive lung disease (HP:0006536) | 1.68129527 |
| 100 | Focal motor seizures (HP:0011153) | 1.67123186 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.32622608 |
| 2 | FES | 2.76202647 |
| 3 | TAOK3 | 2.55935778 |
| 4 | CASK | 2.48703863 |
| 5 | MAPK13 | 2.36756562 |
| 6 | TXK | 2.20538313 |
| 7 | SIK2 | 2.05008591 |
| 8 | CDK19 | 1.96049055 |
| 9 | ITK | 1.95769866 |
| 10 | KIT | 1.94502364 |
| 11 | MARK1 | 1.93325431 |
| 12 | TEC | 1.87413024 |
| 13 | FRK | 1.82949825 |
| 14 | BCKDK | 1.82318140 |
| 15 | SYK | 1.80897048 |
| 16 | GRK6 | 1.71921059 |
| 17 | WNK3 | 1.71092393 |
| 18 | MAP2K7 | 1.68268662 |
| 19 | BTK | 1.67240924 |
| 20 | MAP4K2 | 1.64718087 |
| 21 | CAMKK2 | 1.58463131 |
| 22 | TNK2 | 1.56734419 |
| 23 | PIM2 | 1.55269326 |
| 24 | IKBKE | 1.54260193 |
| 25 | MAP3K4 | 1.54011273 |
| 26 | BLK | 1.48890015 |
| 27 | NUAK1 | 1.47883223 |
| 28 | LYN | 1.45058055 |
| 29 | RIPK4 | 1.41162546 |
| 30 | DAPK2 | 1.36935478 |
| 31 | HCK | 1.36787031 |
| 32 | NTRK2 | 1.22888162 |
| 33 | MAP3K6 | 1.21104775 |
| 34 | DYRK2 | 1.13338165 |
| 35 | LCK | 1.12409626 |
| 36 | KDR | 1.12202372 |
| 37 | PINK1 | 1.10569638 |
| 38 | IRAK4 | 1.06463087 |
| 39 | IKBKB | 1.02172413 |
| 40 | JAK3 | 1.01478102 |
| 41 | MATK | 1.01350987 |
| 42 | PRKCQ | 1.01017996 |
| 43 | CSK | 1.00928799 |
| 44 | PIM1 | 0.96729893 |
| 45 | MAP3K5 | 0.94774698 |
| 46 | EPHA3 | 0.94541001 |
| 47 | FGR | 0.90828327 |
| 48 | DYRK1A | 0.89966780 |
| 49 | ZAP70 | 0.89764340 |
| 50 | ADRBK2 | 0.89163770 |
| 51 | SGK2 | 0.88798081 |
| 52 | PRPF4B | 0.88072822 |
| 53 | PLK2 | 0.86739999 |
| 54 | MAP2K4 | 0.84001912 |
| 55 | OBSCN | 0.83763730 |
| 56 | JAK2 | 0.82691572 |
| 57 | DYRK1B | 0.82169144 |
| 58 | CSF1R | 0.81169086 |
| 59 | TYK2 | 0.81134193 |
| 60 | MAP3K14 | 0.80318387 |
| 61 | CAMKK1 | 0.78600851 |
| 62 | ERBB3 | 0.76986056 |
| 63 | PIK3CG | 0.75856809 |
| 64 | SIK3 | 0.75011170 |
| 65 | GRK1 | 0.71931164 |
| 66 | TNIK | 0.68239318 |
| 67 | PHKG1 | 0.67129240 |
| 68 | PHKG2 | 0.67129240 |
| 69 | IRAK1 | 0.66608530 |
| 70 | SGK223 | 0.66365338 |
| 71 | SGK494 | 0.66365338 |
| 72 | GRK7 | 0.63628096 |
| 73 | TBK1 | 0.63345767 |
| 74 | FYN | 0.62111745 |
| 75 | CDK3 | 0.61785919 |
| 76 | MARK2 | 0.61604817 |
| 77 | CDK6 | 0.59211999 |
| 78 | STK11 | 0.58684741 |
| 79 | CSNK1G2 | 0.58236643 |
| 80 | MAPK12 | 0.57017729 |
| 81 | PRKCZ | 0.55920809 |
| 82 | EIF2AK3 | 0.55178731 |
| 83 | MAPK7 | 0.53737409 |
| 84 | ABL1 | 0.52523392 |
| 85 | PTK2B | 0.51448310 |
| 86 | PASK | 0.51187789 |
| 87 | PRKCE | 0.50554420 |
| 88 | BCR | 0.50515021 |
| 89 | MAP3K7 | 0.49575415 |
| 90 | JAK1 | 0.48858832 |
| 91 | CAMK4 | 0.47688578 |
| 92 | YES1 | 0.46953712 |
| 93 | CDK5 | 0.43372292 |
| 94 | PAK3 | 0.41427453 |
| 95 | RPS6KA5 | 0.41396153 |
| 96 | AKT3 | 0.41256004 |
| 97 | TAOK1 | 0.41194513 |
| 98 | CHUK | 0.40855756 |
| 99 | RPS6KA4 | 0.40301461 |
| 100 | MAP2K3 | 0.39065018 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 4.06092985 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.79027403 |
| 3 | Asthma_Homo sapiens_hsa05310 | 3.77671398 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.70570678 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.68696139 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.60225068 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.82714335 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.72318967 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.20930432 |
| 10 | Viral myocarditis_Homo sapiens_hsa05416 | 2.10745708 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.03921827 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.03742257 |
| 13 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.87352008 |
| 14 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.83665465 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 1.80917579 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.66821103 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.51826021 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.49891557 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.37964706 |
| 20 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.37416068 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.37059270 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.33653207 |
| 23 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.29766166 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.28425737 |
| 25 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.26481379 |
| 26 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.26348640 |
| 27 | Measles_Homo sapiens_hsa05162 | 1.20345473 |
| 28 | Phagosome_Homo sapiens_hsa04145 | 1.17864115 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.11481472 |
| 30 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.09904376 |
| 31 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.97021605 |
| 32 | Nicotine addiction_Homo sapiens_hsa05033 | 0.96663472 |
| 33 | Taste transduction_Homo sapiens_hsa04742 | 0.96474835 |
| 34 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.95655605 |
| 35 | Circadian entrainment_Homo sapiens_hsa04713 | 0.92416825 |
| 36 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.92236262 |
| 37 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.91957990 |
| 38 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.91751207 |
| 39 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.90986857 |
| 40 | Morphine addiction_Homo sapiens_hsa05032 | 0.88458259 |
| 41 | GABAergic synapse_Homo sapiens_hsa04727 | 0.86679655 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.86539495 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85747114 |
| 44 | Influenza A_Homo sapiens_hsa05164 | 0.85541444 |
| 45 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.84031680 |
| 46 | Long-term depression_Homo sapiens_hsa04730 | 0.82677353 |
| 47 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.79262170 |
| 48 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.76142063 |
| 49 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.74953765 |
| 50 | Phototransduction_Homo sapiens_hsa04744 | 0.73638761 |
| 51 | Legionellosis_Homo sapiens_hsa05134 | 0.67761152 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.66855969 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65065638 |
| 54 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.63188991 |
| 55 | Other glycan degradation_Homo sapiens_hsa00511 | 0.62671948 |
| 56 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60686766 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.59873135 |
| 58 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.59669995 |
| 59 | Olfactory transduction_Homo sapiens_hsa04740 | 0.56402009 |
| 60 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.54999657 |
| 61 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.52304707 |
| 62 | Renin secretion_Homo sapiens_hsa04924 | 0.52042567 |
| 63 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.49871291 |
| 64 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.49286261 |
| 65 | Pertussis_Homo sapiens_hsa05133 | 0.48592854 |
| 66 | Malaria_Homo sapiens_hsa05144 | 0.48185265 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47905707 |
| 68 | Salivary secretion_Homo sapiens_hsa04970 | 0.47629575 |
| 69 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.46635420 |
| 70 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.46149159 |
| 71 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.46007786 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45719964 |
| 73 | Hepatitis C_Homo sapiens_hsa05160 | 0.45069778 |
| 74 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.44289653 |
| 75 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.44036297 |
| 76 | Lysosome_Homo sapiens_hsa04142 | 0.43542384 |
| 77 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43373303 |
| 78 | Shigellosis_Homo sapiens_hsa05131 | 0.42247253 |
| 79 | Hepatitis B_Homo sapiens_hsa05161 | 0.41302259 |
| 80 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.41059026 |
| 81 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.40611248 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39578513 |
| 83 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39010257 |
| 84 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37401110 |
| 85 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.37274077 |
| 86 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37088192 |
| 87 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.36789275 |
| 88 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.35731141 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.35719490 |
| 90 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35481472 |
| 91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.35110766 |
| 92 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.34701917 |
| 93 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.34249245 |
| 94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33187655 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.32903931 |
| 96 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.32897486 |
| 97 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.32520144 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32476597 |
| 99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31991294 |
| 100 | Insulin secretion_Homo sapiens_hsa04911 | 0.31771898 |

